Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MDB Capital Holdings, LLC - Class A common
(NQ:
MDBH
)
3.561
+0.001 (+0.02%)
Streaming Delayed Price
Updated: 10:28 AM EST, Jan 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MDB Capital Holdings, LLC - Class A common
< Previous
1
2
Next >
MDB Capital Holdings Provides Third Quarter 2025 Update
November 20, 2025
Management to Host Conference Call Today at 4:30 p.m. ET
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time
November 11, 2025
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $133B Cardiac Diagnostics Market
October 28, 2025
Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who’s leading and why in the rapidly evolving cardiac diagnostics market
From
PatentVest, Inc.
Via
GlobeNewswire
MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
March 24, 2025
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership
September 24, 2025
From
PatentVest, Inc.
Via
GlobeNewswire
MDB Capital Holdings Plans PatVest IPO
↗
August 27, 2025
Via
The Motley Fool
Topics
Initial Public Offering
Intellectual Property
MDB Capital Holdings Provides Second Quarter 2025 Update
August 27, 2025
Management to Host Conference Call Today at 4:30 p.m. ET
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation
August 27, 2025
From
PatentVest, Inc.
Via
GlobeNewswire
PatentVest Releases First-Ever Quantum Computing Rankings
August 19, 2025
Designed for investors, board members, and CEOs, the latest PatentVest Pulse Report reveals which companies are emerging as true leaders as quantum computing shifts from R&D to commercialization
From
PatentVest, Inc.
Via
GlobeNewswire
MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time
August 14, 2025
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market
July 10, 2025
Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who’s actually leading and why in one of the most underpenetrated markets in medtech
From
PatentVest, Inc.
Via
GlobeNewswire
12 Financials Stocks Moving In Friday's Intraday Session
↗
June 13, 2025
Via
Benzinga
MDB Capital Holdings Announces Transitions In Its Board of Directors
June 02, 2025
Matthew Hayden transitions to new strategic role; Dan Torpey appointed Audit Committee Chair
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
MDB Capital Holdings Provides First Quarter 2025 Update
May 21, 2025
Management to Host Conference Call Today at 4:30 p.m. ET
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
May 14, 2025
Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk
From
PatentVest, Inc.
Via
GlobeNewswire
MDB Capital Holdings to Host First Quarter 2025 Results Conference Call on Wednesday May 21, 2025, at 4:30 p.m. Eastern Time
May 14, 2025
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
April 01, 2025
Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who’s winning—and why—in the emerging BCI market
From
PatentVest, Inc.
Via
GlobeNewswire
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
March 31, 2025
Management to Host Conference Call Today at 4:30 p.m. ET
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
Earnings Scheduled For March 31, 2025
↗
March 31, 2025
Via
Benzinga
New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
March 05, 2025
•China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure
From
PatentVest, Inc.
Via
GlobeNewswire
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
February 19, 2025
From
eXoZymes Inc.
Via
GlobeNewswire
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
February 12, 2025
From
eXoZymes Inc.
Via
GlobeNewswire
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
February 10, 2025
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025
From
Invizyne Technologies, Inc.
Via
GlobeNewswire
Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change
January 07, 2025
From
PatentVest, Inc.
Via
GlobeNewswire
MDB Capital Holdings Provides Third Quarter 2024 Update
November 21, 2024
Management to Host Conference Call Today at 4:30 p.m. ET
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
November 19, 2024
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development
From
Invizyne Technologies, Inc.
Via
GlobeNewswire
MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
November 15, 2024
From
MDB Capital Holdings, LLC
Via
GlobeNewswire
Invizyne Technologies Announces Closing of Initial Public Offering
November 14, 2024
From
Invizyne Technologies, Inc.
Via
GlobeNewswire
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
November 13, 2024
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
From
Invizyne Technologies, Inc.
Via
GlobeNewswire
Invizyne Technologies Begins Trading on NASDAQ
November 13, 2024
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
From
Invizyne Technologies, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
